As you correctly stated, this decision concerns dietary...

First 15143 Last

Share
Profile

Follow
MickeyMantle536

933 Posts.

1446

30/01/23

18:45

Post #: 65956774
Share

Originally posted by Rickali01 ↑

Hi Kingkev

Reading the articles that have been published about this specific topic over the last few days, IMHO the key part of the discussion relates to 'supplements and food additives' and a reluctance to regulate this part of the market.

At first glance this does appear concerning and whilst it doesn't sound great, I am assuming that the FDA's view on CBD as a supplement could be different from their view on CBD as a medicine, in the same way that Oxycontin is probably not approved by the FDA as something that you can mix with your energy drinks, but is approved by the FDA to treat acute severe pain.

Interestingly, they have kicked it back congress to find a solution, recognising that this is a rapidly growing industry and there is only so long that they can all sit and do nothing.

For the record, I think CBD should be approved as a supplement - in my experience it is an excellent substitute for opiod based medication - it achieves the same outcome but doesn't stuff your system up (again - in my experience).

Given I hold a fair chunk of IHL shares, I hope the above perspective is the right one. Over the next few months I suspect it will become increasingly clear as we look to progress our various programs through the FDA approval process.

Good luck everyone - hoping 2023 is significantly better than the one we just exited.

Expand

As you correctly stated, this decision concerns dietary supplements and food additives.

IHL is operating in a regulated pharmaceutical environment using molecules that have already received FDA approval.

IHL Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

Top Stories

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

MCT

Metalicity looking for offers on Admiral Bay zinc project

Talking Australia's very competitive property landscape: Realty Talks

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

AI stocks: What to expect in 2024-25

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

There are more pages in this discussion • 4,842 more messages in this thread...

First 15143 Last

Add IHL (ASX) to my watchlist

As you correctly stated, this decision concerns dietary...

Top Stories

Imricor raises $35M to pursue growth and expansion into Australia and NZ

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Metalicity looking for offers on Admiral Bay zinc project

Talking Australia's very competitive property landscape: Realty Talks

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

AI stocks: What to expect in 2024-25

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Featured News